MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 10.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Arzneimittelhersteller |
Börse |
NASDAQ CAPITAL |
Anteile |
1.24 M |
Marktkapitalisierung |
$ 1.37 M |
EBITDA (LTM) |
$ -5.22 M |
P/E (LTM) |
-0.56 |
P/S (LTM) |
0.09 |
EPS (LTM) |
-2.19 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
$ 5.87 | 6.53 % | $ 87.2 M | Nasdaq Global Select Market | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Cronos Group
CRON
|
$ 2.74 | 0.37 % | $ 1.05 B | Nasdaq Global Market | Canada |
 |
Harrow Health
HROW
|
$ 33.0 | 0.12 % | $ 1.21 B | Nasdaq Global Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Organogenesis Holdings
ORGO
|
$ 2.66 | - | $ 337 M | Nasdaq Capital Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 23.35 | -0.55 % | $ 1.08 B | Nasdaq Global Select Market,SPB | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Bausch Health Companies
BHC
|
$ 5.47 | 0.37 % | $ 2 B | NYSE | Canada |
 |
Canopy Growth Corporation
CGC
|
$ 1.04 | -2.8 % | $ 112 M | Nasdaq Global Select Market | Canada |
 |
Tilray
TLRY
|
$ 5.29 | -3.11 % | $ 3.27 B | Nasdaq Global Select Market | Canada |
 |
Solid Biosciences
SLDB
|
$ 6.62 | 1.85 % | $ 579 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurora Cannabis
ACB
|
$ 3.46 | -2.81 % | $ 190 M | NYSE | Canada |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.12 | -0.88 % | $ 107 M | Nasdaq Global Select Market | Canada |
 |
Evolus
EOLS
|
$ 6.09 | -5.58 % | $ 393 M | Nasdaq Global Market | USA |
 |
Sundial Growers
SNDL
|
$ 1.45 | -1.36 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Emergent BioSolutions
EBS
|
$ 8.45 | 0.96 % | $ 433 M | NYSE,SPB | USA |
 |
Veru
VERU
|
$ 2.35 | 5.86 % | $ 34.4 M | Nasdaq Capital Market | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
cbdMD
YCBD
|
$ 0.76 | -2.32 % | $ 3.06 M | NYSE American | USA |
 |
Assertio Holdings
ASRT
|
$ 23.44 | 0.3 % | $ 150 M | Nasdaq Capital Market | USA |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Relmada Therapeutics
RLMD
|
$ 7.04 | -2.36 % | $ 278 M | Nasdaq Global Select Market,SPB | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
SCYNEXIS
SCYX
|
$ 0.73 | 3.0 % | $ 36.5 M | Nasdaq Global Select Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Viatris
VTRS
|
$ 16.65 | 1.15 % | $ 19.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |
 |
Rockwell Medical
RMTI
|
$ 0.79 | -2.06 % | $ 28.4 M | Nasdaq Global Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
China Pharma Holdings
CPHI
|
$ 0.76 | -0.29 % | $ 3.26 M | NYSE American |  China |
 |
TherapeuticsMD
TXMD
|
$ 2.12 | 0.47 % | $ 24.5 M | Nasdaq Global Select Market | USA |